Study reveals hidden inactive form of p38a protein

p38a protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions.

Opinion | Time to Stop Violence in the Healthcare Work Environment

David Nash is the Founding Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at the Jefferson College of Population

March 19, 2024

AD/PD 2024: Eli Lilly’s donanemab hit with FDA delay – Pharmaceutical Technology

Share this article The approval date for Eli Lilly’s donanemab has been pushed from the previously expected time in 1Q 2024 to a date as

March 11, 2024

Boston Scientific gives first look at Farapulse US rollout

By the numbers Q1 sales: $3.86 billion 13.8% increase year over year Cardiovascular sales: $2.45 billion Nearly 16% increase year over year Net income: $493

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.